Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide

Lisa K. Kelly, Nicolas F M Porta, Denise M. Goodman, Christopher L. Carroll, Robin H Steinhorn

Research output: Contribution to journalArticle

126 Scopus citations

Abstract

We report the use of inhaled prostacyclin (PGI2) in 4 neonates with persistent pulmonary hypertension and hypoxemia refractory to inhaled nitric oxide. Oxygenation rapidly improved after inhalation of PGI2 in all infants. The condition of one infant subsequently deteriorated, and alveolar capillary dysplasia was found at autopsy. The surviving infants were discharged with normal oxygen saturations in room air.

Original languageEnglish (US)
Pages (from-to)830-832
Number of pages3
JournalJournal of Pediatrics
Volume141
Issue number6
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide'. Together they form a unique fingerprint.

  • Cite this